An Irish company was due to launch a novel newborn screening test for phenylketonuria (PKU) at a major international meeting in Prague this week. Enzolve Technologies was due to formally launch its diagnostic test at the 6th International Society for Neonatal Screening European Regional Meeting, which took place in Prague from April 26-28...
Read full article on the web Irish Medical Times Apr 29, 2009 or in pdf format
Products & Services
Website supported by